N23068
yw43b02.s1 Weizmann Olfactory Epithelium Homo sapiens cDNA clone IMAGE:254955 3' similar to gb:K01144 HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, GAMMA CHAIN PRECURSOR (HUMAN), mRNA sequence.
489
mRNA
Homo sapiens
LF830224
JP 2016528161-A/23057: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
HZ527849
JP 2016501039-A/23068: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PA338716
JP 2021522188-A/23068: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
OG659454
JP 2021500321-A/23068: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
HW188096
JP 2013102767-A/23020: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
PA393791
JP 2021533803-A/22874: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
MB763750
JP 2018535655-A/27647: ASGR INHIBITORS.
11
PRT
synthetic construct
PD710982
JP 2021530475-A/23064: De novo Design of Protein Switches.
59
PRT
synthetic construct
MD269201
JP 2020517247-A/23068: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
OG752587
JP 2021120380-A/23068: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
LV568890
JP 2017029159-A/23068: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
LF682289
JP 2016521556-A/23068: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
DL613670
JP 2011092200-A/23068: NEISSERIAL ANTIGENIC PEPTIDES.
9
PRT
Neisseria
OG507254
JP 2018534252-A/23068: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
36
PRT
synthetic construct
MC551568
JP 2019525738-A/23068: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
11
PRT
synthetic construct
DL032082
JP 2005512499-A/23068: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
582
DNA
synthetic construct
FU797549
JP 2009528046-A/23066: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
DM797526
JP 2014068652-A/23068: NEISSERIAL ANTIGENIC PEPTIDES.
9
PRT
Neisseria
MC906806
JP 2018536623-A/23068: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
36
PRT
synthetic construct
MC775178
JP 2018525446-A/23068: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
42
PRT
synthetic construct
LX120684
JP 2017506877-A/23066: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
MC164912
JP 2019500349-A/23068: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
HW858292
JP 2015051004-A/23020: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DJ152448
JP 2007228956-A/23066: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
DM759762
JP 2014079248-A/23068: NEISSERIAL ANTIGENIC PEPTIDES.
9
PRT
Neisseria
HV879609
JP 2010507387-A/23020: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
PA527552
JP 2022502046-A/10334: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DD549671
JP 2004508801-A/23068: NEISSERIAL ANTIGENIC PEPTIDES.
9
PRT
Neisseria
DL904812
JP 2014205669-A/23068: Method of constructing and screening libraries of peptide structures.
25
PRT
synthetic construct